Most patients taking opioid painkillers are willing to fill a prescription for the opioid overdose antidote naloxone, a new small study suggests. Prescribing naloxone to patients taking opioid painkillers is increasingly recommended by medical guidelines, HealthDay reports.
The American Academy of Pediatrics is recommending that pediatricians consider offering medication-assisted treatment, such as buprenorphine, for teen and young adult patients with severe opioid use disorders, USA Today reports.
Many insurance companies require patients who have been prescribed the opioid addiction treatment Suboxone to get prior authorization, NPR reports. This requirement can take days or weeks, leaving patients vulnerable to relapse, one expert says.
Critics of the opioid overdose antidote naloxone say the treatment encourages repeated drug use, according to The New York Times. Many people overdose more than once, sometimes many times, and naloxone brings them back each time.
A new study finds people addicted to opioids who are treated with the newly approved implanted form of buprenorphine are more likely to maintain abstinence after six months, compared with those taking the pill form of the treatment.
Doctors who in the past were only allowed to treat 100 patients at a time with the opioid addiction medication buprenorphine will now be able to treat up to 275 patients, Secretary of Health and Human Services Sylvia Burwell announced.
Doctors say they are finding it challenging to add the newly approved addiction treatment medicine Probuphine to their practice, WBEZ reports. They say they have to learn how to implant the drug in the upper arm of patients. They must also deal with new requirements.